newsfilter
← Latest News
CNBC·

Measles is surging in the U.S. — and outbreaks can cost millions

Summary

  • The U.S. is expected to lose its official measles elimination status following a Pan American Health Organization review due to rising case numbers.
  • More than 5,100 measles cases were reported nationwide in 2026 as of early November, representing the worst outbreak in over three decades.
  • Eight deaths associated with the disease were confirmed in 2026: six in Pennsylvania, one in New York, and one in Wisconsin.
  • A Johns Hopkins University tool estimates the 2026 outbreak cost nearly $83 million, including $56 million in public health response costs, almost $25 million in lost productivity, and more than $1.8 million in direct medical expenses.
  • The 2025 outbreak, involving 2,289 confirmed cases, carried an estimated economic cost of more than $37 million.
  • New York's 48 cases in 2025 carried estimated costs of $1.1 million, including nearly $749,000 in public health responses.
  • Texas's 803 cases in 2025 carried estimated costs of nearly $13 million, including $9 million in public health costs.
  • Measles containment requires public health officials to investigate infections, notify exposed individuals, coordinate with institutions, and organize vaccination campaigns.
  • A 2025 study by Joey Mattingly estimated a hypothetical 1,500-case outbreak could cost about $90 million, including roughly $26 million in productivity losses.
  • Quarantining a single person exposed to measles can result in approximately $300 in lost productivity.
  • If one case exposes 40 to 50 people who must quarantine, the resulting lost productivity could total $12,000 to $15,000 even if no contacts become sick.
  • A previous model estimated a fixed cost of roughly $298,000 plus $16,300 for each additional case, though it excluded productivity losses.
  • The economic burden of outbreaks often falls directly on local health departments, requiring them to divert resources from other priorities.

A new tool developed by Johns Hopkins researchers estimates that the 2025 measles outbreak in the U.S. carried an economic cost of more than $37 million.

Keywords
Breaking News: Business,Health care industry,Pharmaceuticals,Biotech and Pharmaceuticals,Biotechnology,Business,Medication,Social issues,Science,United States,business news